Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2 study to determine the efficacy and safety of canfosfamide treatment in
relapsed or refractory mantle cell lymphoma, diffuse large B cell lymphoma and multiple
myeloma. The study will be conducted in two stages with 5-6 patients in each indication in
Stage 1 and if responses are observed an additional 10 patients in Stage 2 in each group.